Crohn's Disease Clinical Trials 2024

Crohn's Disease Clinical Trials 2024

Crohn's Disease research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in crohn's disease clinical trials today.

Crohn's Disease Clinical Trials

Here are the 6 most popular medical studies for crohn's disease

Popular filter options for crohn's disease trials

Inflammatory Bowel Disease Clinical Trials

View 28 Inflammatory Bowel Disease medical studies.

Ulcerative Colitis Clinical Trials

View 28 Ulcerative Colitis medical studies.

Phase 3 Crohn's Disease Clinical Trials

View 98 phase 3 crohn's disease medical studies.

Crohn's Disease Clinical Trials With No Placebo

View 98 crohn's disease medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to crohn's disease

What are the top hospitals conducting crohn's disease research?

When it comes to advancing the treatment options for individuals with Crohn's disease, several hospitals are leading the charge. Boston Children's Hospital in Boston is at the forefront of research and innovation, currently conducting eight active clinical trials for this condition. Since their first recorded trial in 2015, they have completed a total of 15 trials dedicated to understanding and improving outcomes for those living with Crohn's disease.

Moving south to Clearwater, Florida, Gastro Florida is also making significant strides in Crohn's disease research. With seven ongoing trials and a history of 14 previous studies since their initial trial in 2017, this hospital is actively contributing to the body of knowledge surrounding this chronic inflammatory bowel disorder.

In Nashville, Tennessee, Vanderbilt University Medical Center has established itself as a prominent institution when it comes to studying Crohn's disease. Currently engaged in seven active clinical trials and having conducted an impressive total of 46 trials since their inaugural investigation in 2004.

Indiana University located in Indianapolis plays its part too; engaging six active crohn’s diseases investigations while having expertise stemming from fifteentrials through starting early work on tackling such cases back towards2007

Yale University based out New Haven might be smaller-scale but still holds valuable contributions by carrying out six contemporary tests whilst maintaining record building nineinvestigations only dating back until 2014.

These hospitals represent beacons of hope for individuals affected by Crohn's disease worldwide. By investing significant resources into clinical trials focused on enhancing our understanding and treatment options for this complex condition these institutions play crucial roles aidingin shaping better future outlooks not just locally but globally

Which are the best cities for crohn's disease clinical trials?

When it comes to crohn's disease clinical trials, several cities emerge as top contenders for cutting-edge research. New york leads the way with 49 active trials focusing on promising treatments like Ozanimod, Risankizumab SC, and PF-06651600. Miami follows closely behind with 37 ongoing studies investigating potential breakthroughs such as Ozanimod, Mirikizumab, and Etrasimod. Atlanta also stands out with 33 active trials exploring treatment options like Ozanimod, Mirikizumab, and Ustekinumab. Additionally, Chicago and Orlando showcase their commitment to advancing crohn's disease care through their respective 27 and 26 active trials that delve into promising interventions including Ozanimod, Upadacitinib, Mirikizumab, Guselkumab Dose 3. These cities offer individuals living with crohn's disease opportunities to participate in groundbreaking clinical trials that hold promise for improved management of the condition.

Which are the top treatments for crohn's disease being explored in clinical trials?

Crohn's disease, a challenging condition to manage, has seen promising advancements in recent clinical trials. Leading the pack is ozanimod, currently being explored in five active trials dedicated to this chronic inflammatory disorder since its introduction in 2018. Close behind is ustekinumab with three ongoing studies and an impressive track record of 27 all-time crohn's disease trials since 2013. Also vying for attention is mirikizumab which shares similar stats as ustekinumab—three active trials and five all-time crohn's disease trials starting from 2016. Lastly, resistant starch joins the race with two active and two all-time crohn's disease trials listed from 2020 onwards. These cutting-edge treatments offer hope for improved management and quality of life for patients grappling with Crohn’s disease.

What are the most recent clinical trials for crohn's disease?

Recent clinical trials have brought new hope to individuals living with Crohn's disease, a challenging condition that affects the digestive system. One groundbreaking study focuses on guselkumab IV, an open-label induction phase treatment for Crohn's disease that has entered Phase 3 of testing, becoming available for participants from September 21, 2023. Another promising trial involves ozanimod and its potential application in managing Crohn's disease; it has reached Phases 2 and 3 as of August 22, 2023. Additionally, there is ongoing research into the effectiveness of anti-IL12/23 or anti-IL23 medications in treating Crohn's disease during its Phase 4 stage since August1st, 2023. These advancements bring optimism to patients seeking better outcomes through cutting-edge therapies tailored specifically for their needs.

What crohn's disease clinical trials were recently completed?

Recently completed clinical trials for Crohn's disease have shown promising advancements in the field. Stanford University successfully concluded a trial investigating the use of Vitamin d in July 2021, while UCB Biopharma SRL wrapped up their study on certolizumab pegol pharmacokinetics in June 2020. AbbVie also reached a significant milestone with their Risankizumab trial in May 2020. These trials, along with others conducted by Reistone Biopharma Company Limited, Genentech Inc., Janssen-Cilag Ltd., and other reputable sponsors, contribute to our understanding of potential treatments for Crohn's disease and offer hope to patients navigating this challenging condition.